查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1890975

注射型流感疫苗市场按疫苗类型、价数、给药途径、年龄层、技术平台、通路、适应症、株类型和地区划分

Injection Flu Shot Market, By Vaccine Type, By Valency, By Route of Administration, By Age Group, By Technology Platform, By Distribution Channel, By Indication, By Strain Type, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年，注射型流感疫苗市场规模将达到 91.2 亿美元，到 2032 年将达到 150.3 亿美元，2025 年至 2032 年的复合年增长率为 7.4%。

报告内容 报告详情
基准年： 2024 2025年市场规模： 91.2亿美元
历史数据时期： 2020-2024 预测期： 2025-2032
预测期间（2025-2032年）： 7.40% 2032 年的预测值： 150.3亿美元

全球注射型流感疫苗市场是全球免疫领域的重要组成部分，涵盖了透过肌肉注射给药的流感疫苗的研发、生产和分销。这些疫苗是预防季节性流感的主要手段，季节性流感每年影响全球数百万人，造成重大的公共卫生和经济负担。注射型流感疫苗市场包含多种疫苗配方，旨在提供多种流感病毒株的保护，其中包括三价和四价灭活流感疫苗、减毒活病毒疫苗和重组流感疫苗。

市场动态受多种因素影响，例如季节性需求模式、政府疫苗接种政策、医疗基础设施建设以及不断发展的疫苗技术。大型製药和生技公司持续增加研发投入，以提高疫苗效力、减少副作用并改善生产流程。市场涵盖多种分销管道，包括医院、诊所、药房和大型疫苗接种中心，并服务从儿童到老年人的各个年龄层。在全球注射型流感疫苗市场持续发展的推动下，技术进步以及已开发市场和新兴市场疫苗接种管道的不断扩大，加之人们对预防性医疗保健和疫苗接种计划经济效益的认识不断提高，推动了全球注射型流感疫苗市场的发展。

市场动态

全球注射型流感疫苗市场正加速成长，这主要得益于几个关键驱动因素。政府加强对疫苗接种计画的投入和支持力度，尤其是在应对流感大流行和季节性流感疫情方面，是推动市场成长的主要因素。消费者健康意识的提高，以及老年人口的增长（老年人口更容易出现流感併发症），显着推动了市场需求。疫苗研发的进步，包括细胞培养和重组疫苗等生产技术的进步，提高了疫苗的有效性和安全性，从而提高了患者的接受度。新兴经济体医疗基础设施的扩建和低温运输物流的改善，也促进了疫苗的分发和供应。

然而，该市场也面临着许多显着的限制因素，包括部分人口对疫苗的犹豫态度、对副作用的担忧以及可能延缓产品核可和上市的复杂监管流程。季节性需求波动给製造商的供应链和库存管理带来挑战。高昂的研发成本，尤其是在开发通用流感疫苗方面，对市场相关人员造成了财务压力。此外，来自其他接种管道（例如鼻喷疫苗）的竞争可能会限制注射产品的市场份额。儘管存在这些挑战，但开发中国家拥有大量未接种疫苗的人口）、可能提供长期保护的通用流感疫苗的研发以及数位健康技术在改善疫苗接种追踪和患者参与度方面的应用，都蕴藏着巨大的机会。

本次调查的主要特点

  • 本报告对全球注射型流感疫苗市场进行了详细分析，以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和復合年增长率（%）。
  • 它还重点介绍了各个细分市场的潜在商机，并解释了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与企业。
  • 该研究根据以下参数对全球注射型流感疫苗市场的主要企业进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球注射型流感疫苗市场报告的目标受众是该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球注射型流感疫苗市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章：市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球注射型流感疫苗市场（依疫苗类型划分）

  • 失活
  • 减毒活病毒疫苗

5. 2020-2032年全球注射型流感疫苗市场（以价态划分）

  • 四价
  • 三价

6. 2020-2032年全球注射型流感疫苗市场（依给药途径划分）

  • 注射
  • 鼻喷雾

7. 2020-2032年全球注射型流感疫苗市场（依年龄层划分）

  • 儿童
  • 成人

8. 2020-2032年全球注射型流感疫苗市场（依技术平台划分）

  • 蛋製品
  • 基于细胞培养
  • 重组
  • 基于mRNA的

9. 2020-2032年全球注射型流感疫苗市场（依通路划分）

  • 医院和零售药局
  • 政府和机构供应商
  • 其他（例如，非政府组织、国际组织）

10. 2020-2032年全球注射型流感疫苗市场（依适应症划分）

  • 季节性
  • 大流行

11. 2020-2032年全球注射型流感疫苗市场（依病毒株类型划分）

  • A（H1N1）
  • A（H3N2）
  • B（山形）
  • B（维多利亚）

12. 2020-2032年全球注射型流感疫苗市场（按地区划分）

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • GCC
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第十三章 竞争格局

  • Sanofi Pasteur
  • GlaxoSmithKline
  • CSL Seqirus
  • AstraZeneca
  • Pfizer
  • Merck
  • Moderna
  • Novavax
  • Bharat BIoTech
  • Sinovac BIoTech
  • Serum Institute of India
  • Daiichi Sankyo
  • Emergent BioSolutions
  • BIKEN Co., Ltd.
  • Abbott Laboratories

第十四章 分析师建议

  • 机会
  • 一致的机会地图

第十五章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8878

Injection Flu Shot Market is estimated to be valued at USD 9.12 Bn in 2025 and is expected to reach USD 15.03 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 9.12 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.40% 2032 Value Projection: USD 15.03 Bn

The global injection flu shot market represents a critical segment within the global immunization landscape, encompassing the development, manufacturing, and distribution of influenza vaccines administered through intramuscular injection. These vaccines serve as the primary prophylactic measure against seasonal influenza, which affects millions of individuals worldwide annually and poses significant public health and economic burdens. The injection flu shot market includes various vaccine formulations such as trivalent and quadrivalent inactivated influenza vaccines, live attenuated influenza vaccines, and recombinant influenza vaccines, each designed to provide protection against multiple influenza virus strains.

The market dynamics are influenced by factors including seasonal demand patterns, government immunization policies, healthcare infrastructure development, and evolving vaccine technologies. Major pharmaceutical companies and biotechnology firms continuously invest in research and development to enhance vaccine efficacy, reduce adverse effects, and improve manufacturing processes. The market encompasses diverse distribution channels including hospitals, clinics, pharmacies, and mass vaccination centers, serving various demographic segments from pediatric to geriatric populations. With increasing awareness about preventive healthcare and the economic benefits of vaccination programs, the global injection flu shot market continues to evolve, driven by technological advancements and expanding accessibility across both developed and emerging markets.

Market Dynamics

The global injection flu shot market is propelled by several key drivers that collectively fuel its growth trajectory. Increasing government initiatives and funding for vaccination programs, particularly in response to pandemic preparedness and seasonal flu outbreaks, serve as primary growth catalysts. Rising healthcare awareness among consumers, coupled with growing elderly populations who are more susceptible to influenza complications, significantly drives market demand. Technological advancements in vaccine development, including cell-based and recombinant vaccine production methods, enhance vaccine efficacy and safety profiles, attracting broader patient acceptance. Expanding healthcare infrastructure in emerging economies and improved cold chain logistics facilitate better vaccine distribution and accessibility.

However, the market faces notable restraints including vaccine hesitancy among certain population segments, concerns about adverse effects, and regulatory complexities that can delay product approvals and market entry. Seasonal demand fluctuations create supply chain challenges and inventory management issues for manufacturers. High research and development costs, particularly for developing universal flu vaccines, pose financial constraints for market players. Additionally, competition from alternative vaccination routes such as nasal spray vaccines may limit market share for injection-based products. Despite these challenges, significant opportunities emerge from untapped markets in developing countries with large unvaccinated populations, development of universal flu vaccines that could provide long-term protection, and integration of digital health technologies for improved vaccination tracking and patient engagement.

Key Features of the Study

  • This report provides in-depth analysis of the global injection flu shot market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global injection flu shot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline, CSL Seqirus, AstraZeneca, Pfizer, Merck, Moderna, Novavax, Bharat Biotech, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, Emergent BioSolutions, BIKEN Co., Ltd., and Abbott Laboratories.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global injection flu shot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injection flu shot market

Market Segmentation

  • Vaccine Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Inactivated
    • Live Attenuated
  • Valency Insights (Revenue, USD Bn, 2020 - 2032)
    • Quadrivalent
    • Trivalent
  • Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
    • Injection
    • Nasal Spray
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Pediatric
    • Adult
  • Technology Platform Insights (Revenue, USD Bn, 2020 - 2032)
    • Egg-based
    • Cell-based
    • Recombinant
    • mRNA-based
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital and Retail Pharmacies
    • Government & Institutional Suppliers
    • Others (e.g., NGOs, International Organizations)
  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Seasonal
    • Pandemic
  • Strain Type Insights (Revenue, USD Bn, 2020 - 2032)
    • A(H1N1)
    • A(H3N2)
    • B (Yamagata)
    • B (Victoria)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Sanofi Pasteur
    • GlaxoSmithKline
    • CSL Seqirus
    • AstraZeneca
    • Pfizer
    • Merck
    • Moderna
    • Novavax
    • Bharat Biotech
    • Sinovac Biotech
    • Serum Institute of India
    • Daiichi Sankyo
    • Emergent BioSolutions
    • BIKEN Co., Ltd.
    • Abbott Laboratories

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Injection Flu Shot Market, By Vaccine Type
    • Global Injection Flu Shot Market, By Valency
    • Global Injection Flu Shot Market, By Route of Administration
    • Global Injection Flu Shot Market, By Age Group
    • Global Injection Flu Shot Market, By Technology Platform
    • Global Injection Flu Shot Market, By Distribution Channel
    • Global Injection Flu Shot Market, By Indication
    • Global Injection Flu Shot Market, By Strain Type
    • Global Injection Flu Shot Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Injection Flu Shot Market, By Vaccine Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Inactivated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Live Attenuated
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Injection Flu Shot Market, By Valency, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Quadrivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Trivalent
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Injection Flu Shot Market, By Route of Administration, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nasal Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Injection Flu Shot Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Injection Flu Shot Market, By Technology Platform, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Egg-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cell-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Recombinant
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • mRNA-based
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Injection Flu Shot Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital and Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Government & Institutional Suppliers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (e.g., NGOs, International Organizations)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Injection Flu Shot Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Seasonal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pandemic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Injection Flu Shot Market, By Strain Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • A(H1N1)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • A(H3N2)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • B (Yamagata)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • B (Victoria)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Injection Flu Shot Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Valency, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology Platform, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strain Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Sanofi Pasteur
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CSL Seqirus
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Moderna
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novavax
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bharat Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sinovac Biotech
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Serum Institute of India
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Daiichi Sankyo
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Emergent BioSolutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BIKEN Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us